600 healthy volunteers test malaria Drug's Long-Term eye safety
NCT ID NCT03320174
First seen Apr 23, 2026 · Last updated Jun 18, 2026 · Updated 16 times
Summary
This study looked at the long-term safety of tafenoquine, a drug used to prevent malaria, in 600 healthy adults. Participants took either tafenoquine or a placebo daily for three days, then weekly for 51 weeks. The main goal was to check for any serious eye problems, with follow-up visits over a year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Linear Clinical Research
Nedlands, Western Australia, 6009, Australia
-
Retina Consultants of Southern Colorado
Colorado Springs, Colorado, 80909, United States
-
Valley Retina Institute
McAllen, Texas, 78503, United States
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.